Drug Shortage Report for APO-OLMESARTAN/HCTZ
Report ID | 16905 |
Drug Identification Number | 02453614 |
Brand name | APO-OLMESARTAN/HCTZ |
Common or Proper name | OLMESARTAN-HCTZ |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | HYDROCHLOROTHIAZIDE OLMESARTAN MEDOXOMIL |
Strength(s) | 12.5MG 40MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 BTL & 30 BLS |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-12-18 |
Estimated end date | 2018-04-30 |
Actual end date | 2018-04-20 |
Shortage status | Resolved |
Updated date | 2018-04-23 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v21 | 2018-02-13 | English | Compare |
v22 | 2018-02-13 | French | Compare |
v23 | 2018-04-23 | English | Compare |
v24 | 2018-04-23 | French | Compare |